Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "There Is Nothing New Except What Has Been Forgotten": The Story of Mechanical Ventilation during Extracorporeal Support.1 passage
• (untitled)5 passages
• 2020 American Thoracic Society BEAR Cage Winning Proposal: Collagen-targeted Positron Emission Tomography Imaging as a Novel Biomarker of Treatment Response in Idiopathic Pulmonary Fibrosis.1 passage
• A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of β-Catenin.1 passage
• A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies.1 passage
• A Critical Care Societies Collaborative Statement: Burnout Syndrome in Critical Care Health-care Professionals. A Call for Action.1 passage
• A Disintegrin and A Metalloproteinase-9 (ADAM9): A Novel Proteinase Culprit with Multifarious Contributions to COPD.1 passage
• A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease.1 passage
• A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life.1 passage
• A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and Tuberculosis.1 passage
• A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.1 passage
• A Genome-Wide Association Study in Hispanics/Latinos Identifies Novel Signals for Lung Function. The Hispanic Community Health Study/Study of Latinos.1 passage
• A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes.1 passage
• A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.1 passage
• A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin.1 passage
• A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.1 passage
• A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).1 passage
• A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).1 passage
• A Multicenter Randomized Trial Assessing the Efficacy of Helium/Oxygen in Severe Exacerbations of Chronic Obstructive Pulmonary Disease.1 passage
• A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.1 passage
• A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.1 passage
• A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma.1 passage
• A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.1 passage
• A Not-So-Good Way to Die? Respiratory Syncytial Virus-induced Necroptotic Cell Death Promotes Inflammation and Type 2-mediated Pathology.1 passage
• A Novel Assay for Neutrophil Extracellular Trap Formation Independently Predicts Disseminated Intravascular Coagulation and Mortality in Critically Ill Patients.1 passage
• A Novel CD41 passage
• A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.1 passage
• A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.1 passage
• A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.1 passage
• A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One1 passage
• A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients.1 passage
• A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!1 passage
• A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.1 passage
• A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER.1 passage
• A Prediction Model to Help with the Assessment of Adenopathy in Lung Cancer: HAL.1 passage
• A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.1 passage
• A Randomized Trial of an Intensive Physical Therapy Program for Patients with Acute Respiratory Failure.1 passage
• A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.1 passage
• A Rapid Pharmacogenomic Assay to Detect1 passage
• A Reappraisal on the Associations between Sleep-disordered Breathing, Insomnia, and Cardiometabolic Risk.1 passage
• A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.1 passage
• A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement.1 passage
• A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.1 passage
• A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED Cohorts.1 passage
• A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension.1 passage
• A Single-Cell Atlas of the Human Healthy Airways.1 passage
• A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia.1 passage
• A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.1 passage
• A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma.1 passage
• A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis.1 passage
• A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.1 passage
• A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission.1 passage
• A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses.1 passage
• AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension.1 passage
• Abnormal Activity of Neck Inspiratory Muscles during Sleep as a Prognostic Indicator in Chronic Obstructive Pulmonary Disease.1 passage
• Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.1 passage
• Accounting for Patient Preferences Regarding Life-Sustaining Treatment in Evaluations of Medical Effectiveness and Quality.1 passage
• Accuracy and Reliability of Internet Resources for Information on Idiopathic Pulmonary Fibrosis.1 passage
• Accuracy of Immunofluorescence in the Diagnosis of Primary Ciliary Dyskinesia.1 passage
• Acid Sphingomyelinase Inhibition Attenuates Cell Death in Mechanically Ventilated Newborn Rat Lung.1 passage
• Acquisition and Transmission of Streptococcus pneumoniae Are Facilitated during Rhinovirus Infection in Families with Children.1 passage
• Activated Leukocyte Cell Adhesion Molecule Stimulates the T-Cell Response in Allergic Asthma.1 passage
• Active and passive smoking and the incidence of asthma in the Black Women's Health Study.1 passage
• Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.1 passage
• Acute Eosinophilic Pneumonia. Causes, Diagnosis, and Management.1 passage
• Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.1 passage
• Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.1 passage
• Acute Kidney Injury Requiring Dialysis in Severe Sepsis.1 passage
• Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness.1 passage
• Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition.1 passage
• Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.1 passage
• Acute Respiratory Distress Syndrome in COVID-19: Do All These Patients Definitely Require Intubation and Mechanical Ventilation?1 passage
• Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.1 passage
• Adopting Clean Fuels and Technologies on School Buses. Pollution and Health Impacts in Children.1 passage
• Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery.1 passage
• Age Effects on Cerebral Oxygenation and Behavior in Children with Sleep-disordered Breathing.1 passage
• Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.1 passage
• Age-Specific Associations of Ozone and Fine Particulate Matter with Respiratory Emergency Department Visits in the United States.1 passage
• Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.1 passage
• Air Pollution and Lung Function in Minority Youth with Asthma in the GALA II (Genes-Environments and Admixture in Latino Americans) and SAGE II (Study of African Americans, Asthma, Genes, and Environments) Studies.1 passage
• Air Pollution as a Risk Factor for Incident Chronic Obstructive Pulmonary Disease and Asthma. A 15-Year Population-based Cohort Study.1 passage
• Air Pollution from Livestock Farms Is Associated with Airway Obstruction in Neighboring Residents.1 passage
• Air Pollution, Genetic Factors, and the Risk of Lung Cancer: A Prospective Study in the UK Biobank.1 passage
• Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis.1 passage
• Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.1 passage
• Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults.1 passage
• Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis.1 passage
• Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease.1 passage
• Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation.1 passage
• Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.1 passage
• Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.1 passage
• Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.1 passage
• Airway Occlusion Pressure As an Estimate of Respiratory Drive and Inspiratory Effort during Assisted Ventilation.1 passage
• Airway Oscillometry Detects Spirometric-Silent Episodes of Acute Cellular Rejection.1 passage
• Airway Pressure Release Ventilation in Pediatric Acute Respiratory Distress Syndrome. A Randomized Controlled Trial.1 passage
• Airway Remodeling in Preschool Children with Severe Recurrent Wheeze.1 passage
• Airway Sensory Nerve Density Is Increased in Chronic Cough.1 passage
• Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.1 passage
• Allergen-induced Changes in Bone Marrow and Airway Dendritic Cells in Subjects with Asthma.1 passage
• Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma.1 passage
• Alpha-1 Antitrypsin MZ Heterozygosity is an Endotype of Chronic Obstructive Pulmonary Disease.1 passage
• Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function.1 passage
• Altered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute Rejection.1 passage
• Alveolar Macrophage Apoptosis-associated Bacterial Killing Helps Prevent Murine Pneumonia.1 passage
• Alveolar Macrophage Transcriptional Programs Are Associated with Outcomes in Acute Respiratory Distress Syndrome.1 passage
• Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19.1 passage
• Ambient Pollution-related Reprogramming of the Human Small Airway Epithelial Transcriptome.1 passage
• Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.1 passage
• American Thoracic Society patient information series. Other therapies for sleep apnea.1 passage
• American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.1 passage
• Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by1 passage
• An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.1 passage
• An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.1 passage
• An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.1 passage
• An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.1 passage
• An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.1 passage
• An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units.1 passage
• An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.1 passage
• An Official American Thoracic Society Clinical Practice Guideline: Pediatric Chronic Home Invasive Ventilation.1 passage
• An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.1 passage
• An Official American Thoracic Society Research Statement: Current Challenges Facing Research and Therapeutic Advances in Airway Remodeling.1 passage
• An Official American Thoracic Society Research Statement: Current Understanding and Future Research Needs in Tobacco Control and Treatment.1 passage
• An Official American Thoracic Society Research Statement: Impact of Mild Obstructive Sleep Apnea in Adults.1 passage
• An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.1 passage
• An Official American Thoracic Society Statement: The Importance of Healthy Sleep. Recommendations and Future Priorities.1 passage
• An Official American Thoracic Society Systematic Review: The Effect of Nighttime Intensivist Staffing on Mortality and Length of Stay among Intensive Care Unit Patients.1 passage
• An Official American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Rehabilitation Protocols, Ventilator Liberation Protocols, and Cuff Leak Tests.1 passage
• An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation.1 passage
• An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.1 passage
• An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.1 passage
• An official American Thoracic Society policy statement: managing conscientious objections in intensive care medicine.1 passage
• An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.1 passage
• Analytical Performance Requirements for Biomarker-based Studies Evaluating Continuous Positive Airway Pressure Effects in Obstructive Sleep Apnea.1 passage
• Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.1 passage
• Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease.1 passage
• Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.1 passage
• Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study.1 passage
• Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.1 passage
• Anti-sFlt-1 Therapy Preserves Lung Alveolar and Vascular Growth in Antenatal Models of Bronchopulmonary Dysplasia.1 passage
• Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis Infection.1 passage
• Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury.1 passage
• Apnea-Hypopnea Event Duration Predicts Mortality in Men and Women in the Sleep Heart Health Study.1 passage
• Application of a Natural Language Processing Algorithm to Asthma Ascertainment. An Automated Chart Review.1 passage
• Applying Precision Medicine to Trial Design Using Physiology. Extracorporeal CO1 passage
• Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis.1 passage
• Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights.1 passage
• Are All Steps Created Equal? Revisiting Pedometer Use during Pulmonary Rehabilitation for Individuals Living with Chronic Obstructive Pulmonary Disease.1 passage
• Arterial Pulse Pressure Variation with Mechanical Ventilation.1 passage
• Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.1 passage
• Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.1 passage
• Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.1 passage
• Assessment of Airway Closure and Expiratory Airflow Limitation to Set Positive End-Expiratory Pressure in Morbidly Obese Patients with Acute Respiratory Distress Syndrome.1 passage
• Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.1 passage
• Assessment of Inflammation in Pulmonary Artery Hypertension by1 passage
• Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.1 passage
• Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.1 passage
• Association between Cardiorespiratory Fitness and Lung Health from Young Adulthood to Middle Age.1 passage
• Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.1 passage
• Association between Glucose Metabolism and Sleep-disordered Breathing during REM Sleep.1 passage
• Association between Household Air Pollution Exposure and Chronic Obstructive Pulmonary Disease Outcomes in 13 Low- and Middle-Income Country Settings.1 passage
• Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.1 passage
• Association between Initiation of Pulmonary Rehabilitation and Rehospitalizations in Patients Hospitalized with Chronic Obstructive Pulmonary Disease.1 passage
• Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants.1 passage
• Association between Troponin I Levels during Sepsis and Postsepsis Cardiovascular Complications.1 passage
• Association of Differential Mast Cell Activation to Granulocytic Inflammation in Severe Asthma.1 passage
• Association of Height Growth in Puberty with Lung Function. A Longitudinal Study.1 passage
• Association of Intensive Care Unit Admission and Outcomes in Sepsis and Acute Respiratory Failure.1 passage
• Association of Premorbid Blood Pressure with Vasopressor Infusion Duration in Patients with Shock.1 passage
• Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.1 passage
• Associations between Inhaled Corticosteroid Use in the First 6 Years of Life and Obesity-related Traits.1 passage
• Associations between Obstructive Sleep Apnea, Sleep Duration, and Abnormal Fasting Glucose. The Multi-Ethnic Study of Atherosclerosis.1 passage
• Associations of Nasopharyngeal Metabolome and Microbiome with Severity among Infants with Bronchiolitis. A Multiomic Analysis.1 passage
• Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos.1 passage
• Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.1 passage
• Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study.1 passage
• Asthma Trajectories in a Population-based Birth Cohort. Impacts of Air Pollution and Greenness.1 passage
• Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?1 passage
• Asthma and the hygiene hypothesis. Does cleanliness matter?1 passage
• Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.1 passage
• Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.1 passage
• Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.1 passage
• Attention to Immortal Time Bias in Critical Care Research.1 passage
• Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.1 passage
• Autophagy Primes Neutrophils for Neutrophil Extracellular Trap Formation during Sepsis.1 passage
• Autophagy in Pulmonary Diseases.1 passage
• Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.1 passage
• Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.1 passage
• B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.1 passage
• B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.1 passage
• BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease.1 passage
• BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.1 passage
• BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications.1 passage
• Bacterial Dissemination to the Brain in Sepsis.1 passage
• Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.1 passage
• Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia.1 passage
• Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.1 passage
• Balanced Crystalloid Solutions.1 passage
• Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.1 passage
• Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial.1 passage
• Bedside Contribution of Electrical Impedance Tomography to Setting Positive End-Expiratory Pressure for Extracorporeal Membrane Oxygenation-treated Patients with Severe Acute Respiratory Distress Syndrome.1 passage
• Bedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory disease.1 passage
• Benefits of Airway Androgen Receptor Expression in Human Asthma.1 passage
• Benefits of Long-Term Pulmonary Rehabilitation Maintenance Program in Patients with Severe Chronic Obstructive Pulmonary Disease. Three-Year Follow-up.1 passage
• Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.1 passage
• Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome.1 passage
• Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.1 passage
• Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.1 passage
• Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.1 passage
• Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.1 passage
• Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.1 passage
• Blood Neutrophils Are Reprogrammed in Bronchiectasis.1 passage
• Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea.1 passage
• Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.1 passage
• Blue journal conference. Aging and susceptibility to lung disease.1 passage
• Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.1 passage
• Bone metastases in lung cancer. Potential novel approaches to therapy.1 passage
• Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.1 passage
• Brain Responses to Propofol in Advance of Recovery From Coma and Disorders of Consciousness: A Preliminary Study.1 passage
• Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis.1 passage
• Bronchial Epithelial IgA Secretion Is Impaired in Asthma. Role of IL-4/IL-13.1 passage
• Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial.1 passage
• Bronchial Smooth Muscle Remodeling in Nonsevere Asthma.1 passage
• Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial.1 passage
• Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis.1 passage
• Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.1 passage
• CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.1 passage
• CC16 Levels into Adult Life Are Associated with Nitrogen Dioxide Exposure at Birth.1 passage
• CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.1 passage
• COVID-19 with Different Severities: A Multicenter Study of Clinical Features.1 passage
• COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.1 passage
• COVID-19-related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.1 passage
• CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.1 passage
• Cadherin-related Family Member 3 Genetics and Rhinovirus C Respiratory Illnesses.1 passage
• Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death.1 passage
• Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study.1 passage
• Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.1 passage
• Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy.1 passage
• Cardiac Magnetic Resonance Imaging Evaluation of Neonatal Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.1 passage
• Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis.1 passage
• Cardiopulmonary Impact of Hypoxic Ischemic Encephalopathy in Newborn Infants. The Emerging Role of Early Hemodynamic Assessment in Determining Adverse Neurological Outcomes.1 passage
• Cardiopulmonary Resuscitation-associated Lung Edema (CRALE). A Translational Study.1 passage
• Cardiotoxicity during invasive pneumococcal disease.1 passage
• Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation.1 passage
• Cardioventilatory Control in Preterm-born Children and the Risk of Obstructive Sleep Apnea.1 passage
• Caring for Critically Ill Patients in Humanitarian Settings.1 passage
• Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis.1 passage
• Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial.1 passage
• Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases.1 passage
• Center Volume and Extracorporeal Membrane Oxygenation Support at Lung Transplantation in the Lung Allocation Score Era.1 passage
• Central Sleep-disordered Breathing Predicts Incident Atrial Fibrillation in Older Men.1 passage
• Cerebral Autoregulation During Orthostatic Challenge in Congenital Central Hypoventilation Syndrome.1 passage
• Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.1 passage
• Changes in Bone Mineral Density in the Year after Critical Illness.1 passage
• Changes in Energy Metabolism after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.1 passage
• Changes to Visitation Policies and Communication Practices in Michigan ICUs during the COVID-19 Pandemic.1 passage
• Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis.1 passage
• Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype.1 passage
• Characteristics and Outcomes of Eligible Nonenrolled Patients in a Mechanical Ventilation Trial of Acute Respiratory Distress Syndrome.1 passage
• Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study.1 passage
• Characterization of1 passage
• Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia.1 passage
• Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.1 passage
• Characterization of the Inflammatory Response to Severe COVID-19 Illness.1 passage
• Checkpoint Blockade in Lung Cancer and Mesothelioma.1 passage
• Chemokine (C-X-C Motif) Ligand 4 Is a Restrictor of Respiratory Syncytial Virus Infection and an Indicator of Clinical Severity.1 passage
• Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.1 passage
• Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies.1 passage
• Childhood Body Composition Trajectories and Adolescent Lung Function. Findings from the ALSPAC study.1 passage
• Childhood Lung Function Predicts Adult Chronic Obstructive Pulmonary Disease and Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.1 passage
• Children's Urinary Environmental Carbon Load. A Novel Marker Reflecting Residential Ambient Air Pollution Exposure?1 passage
• Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation.1 passage
• Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis.1 passage
• Chromosome 17q12-21 Variants Are Associated with Multiple Wheezing Phenotypes in Childhood.1 passage
• Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome.1 passage
• Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung.1 passage
• Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China.1 passage
• Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures.1 passage
• Chronic Hypoxia Accentuates Dysanaptic Lung Growth.1 passage
• Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.1 passage
• Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.1 passage
• Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation.1 passage
• Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.1 passage
• Chronic Obstructive Pulmonary Disease and Breathlessness in Older Workers Predict Economic Inactivity. A Prospective Cohort Study.1 passage
• Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.1 passage
• Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study.1 passage
• Cigarette Smoke Directly Promotes Pulmonary Arterial Remodeling and Kv7.4 Channel Dysfunction.1 passage
• Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.1 passage
• Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.1 passage
• Circulating MicroRNAs and Treatment Response in Childhood Asthma.1 passage
• Circulating Plasma Extracellular Microvesicle MicroRNA Cargo and Endothelial Dysfunction in Children with Obstructive Sleep Apnea.1 passage
• Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.1 passage
• Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.1 passage
• Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.1 passage
• Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis.1 passage
• Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction.1 passage
• Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis.1 passage
• Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.1 passage
• Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.1 passage
• Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.1 passage
• Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients.1 passage
• Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD).1 passage
• Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype.1 passage
• Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders.1 passage
• Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.1 passage
• Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions.1 passage
• Club Cell Secretory Protein Deficiency Leads to Altered Lung Function.1 passage
• Coexistence and Impact of Limb Muscle and Diaphragm Weakness at Time of Liberation from Mechanical Ventilation in Medical Intensive Care Unit Patients.1 passage
• Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.1 passage
• Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification.1 passage
• Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories.1 passage
• Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in Sheep.1 passage
• Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders.1 passage
• Comorbidities and Subgroups of Patients Surviving Severe Acute Hypercapnic Respiratory Failure in the Intensive Care Unit.1 passage
• Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients.1 passage
• Comparative Effectiveness of Protective Ventilation Strategies for Moderate and Severe Acute Respiratory Distress Syndrome. A Network Meta-Analysis.1 passage
• Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California.1 passage
• Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas.1 passage
• Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species.1 passage
• Comparison of Echocardiographic Indices Used to Predict Fluid Responsiveness in Ventilated Patients.1 passage
• Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.1 passage
• Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.1 passage
• Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.1 passage
• Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes.1 passage
• Comparison of video laryngoscopy versus direct laryngoscopy during urgent endotracheal intubation; trial of the route of early nutritional support in critically ill adults; and transfusion of plasma, platelets, and red blood cells in a 1:1:1 versus a 1:1:2 ratio and mortality in patients with severe trauma.1 passage
• Complete Tracheal Ring Deformity. A Translational Genomics Approach to Pathogenesis.1 passage
• Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic.1 passage
• Computed Tomography Measure of Lung at Risk and Lung Function Decline in Chronic Obstructive Pulmonary Disease.1 passage
• Computed Tomography-based Airway Surface Area-to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease.1 passage
• Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.1 passage
• Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis.1 passage
• Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial.1 passage
• Constant Tidal Volume Ventilation and Surfactant Dysfunction: An Overlooked Cause of Ventilator-Induced Lung Injury.1 passage
• Continuous Positive Airway Pressure Adherence for Prevention of Major Adverse Cerebrovascular and Cardiovascular Events in Obstructive Sleep Apnea.1 passage
• Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial.1 passage
• Continuous Positive Airway Pressure Improves Quality of Life in Women with Obstructive Sleep Apnea. A Randomized Controlled Trial.1 passage
• Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.1 passage
• Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes.1 passage
• Contributions of BMPR2 Mutations and Extrinsic Factors to Cellular Phenotypes of Pulmonary Arterial Hypertension Revealed by Induced Pluripotent Stem Cell Modeling.1 passage
• Controlled Chamber Studies Showed Protective Effect of Nonsteroidal Antiinflammatory Drugs against Ozone Exposure: The Stage Was Set for Broader Epidemiologic Investigation.1 passage
• Conventional Polysomnography Is Not Necessary for the Management of Most Patients with Suspected Obstructive Sleep Apnea. Noninferiority, Randomized Controlled Trial.1 passage
• Core Outcome Measures for Clinical Research in Acute Respiratory Failure Survivors. An International Modified Delphi Consensus Study.1 passage
• Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.1 passage
• Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.1 passage
• Critical Care Management of Chimeric Antigen Receptor T Cell-related Toxicity. Be Aware and Prepared.1 passage
• Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.1 passage
• Critical care bed growth in the United States. A comparison of regional and national trends.1 passage
• Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features. Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial.1 passage
• Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.1 passage
• Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.1 passage
• Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.1 passage
• Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.1 passage
• Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.1 passage
• Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood.1 passage
• Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.1 passage
• DJ-1/PARK7 Impairs Bacterial Clearance in Sepsis.1 passage
• DNA Methylation Is Predictive of Mortality in Current and Former Smokers.1 passage
• DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung Fibrosis.1 passage
• Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.1 passage
• Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.1 passage
• De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.1 passage
• Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis.1 passage
• Defective Fibrillar Collagen Organization by Fibroblasts Contributes to Airway Remodeling in Asthma.1 passage
• Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.1 passage
• Depletion of Airway Submucosal Glands and TP631 passage
• Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing.1 passage
• Desipramine Increases Genioglossus Activity and Reduces Upper Airway Collapsibility during Non-REM Sleep in Healthy Subjects.1 passage
• Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis.1 passage
• Detecting Deteriorating Patients in the Hospital: Development and Validation of a Novel Scoring System.1 passage
• Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.1 passage
• Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening.1 passage
• Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.1 passage
• Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease.1 passage
• Deterioration of Regional Lung Strain and Inflammation during Early Lung Injury.1 passage
• Determinants of Intensive Care Unit Telemedicine Effectiveness. An Ethnographic Study.1 passage
• Determinants of Lung Fissure Completeness.1 passage
• Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.1 passage
• Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.1 passage
• Developing a clinically feasible personalized medicine approach to pediatric septic shock.1 passage
• Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.1 passage
• Development and Preliminary Validation of the Lung Transplant Quality of Life (LT-QOL) Survey.1 passage
• Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.1 passage
• Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.1 passage
• Development and Validation of SDBeasy Score as a Predictor of Behavioral Outcomes in Childhood.1 passage
• Development of A Blood-Based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease.1 passage
• Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.1 passage
• Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.1 passage
• Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex.1 passage
• Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.1 passage
• Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.1 passage
• Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.1 passage
• Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia.1 passage
• Diagnostic Classification of Bronchopulmonary Dysplasia: A Compromise between Defining Lung Disease versus Long-Term Outcome Prediction.1 passage
• Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction.1 passage
• Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.1 passage
• Diagnostic Yield and Complications of Bronchoscopy for Peripheral Lung Lesions. Results of the AQuIRE Registry.1 passage
• Diaphragm Atrophy and Weakness in the Absence of Mitochondrial Dysfunction in the Critically Ill.1 passage
• Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients.1 passage
• Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant.1 passage
• Dibutyl Phthalate Augments Allergen-induced Lung Function Decline and Alters Human Airway Immunology. A Randomized Crossover Study.1 passage
• Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis.1 passage
• Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies.1 passage
• Differential Expression of VEGF-A1 passage
• Differential Gene Expression of Lymphocytes Stimulated with Rhinovirus A and C in Children with Asthma.1 passage
• Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease History.1 passage
• Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.1 passage
• Diffuse Cystic Lung Disease. Part I.1 passage
• Diffuse Cystic Lung Disease. Part II.1 passage
• Disconnect between Fibrotic Response and Right Ventricular Dysfunction.1 passage
• Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.1 passage
• Disease Management plus Recommended Care versus Recommended Care Alone for Ambulatory Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Disease Progression Modeling in Chronic Obstructive Pulmonary Disease.1 passage
• Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Disease Staging and Prognosis in Smokers Using Deep Learning in Chest Computed Tomography.1 passage
• Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort Study.1 passage
• Disparities in pulmonary function in healthy children across the Indian urban-rural continuum.1 passage
• Distinct "Immunoallertypes" of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis.1 passage
• Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function.1 passage
• Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections.1 passage
• Do Patients of Subspecialist Physicians Benefit from Written Asthma Action Plans?1 passage
• Do We Really Doubt Extracorporeal Membrane Oxygenation Efficacy in Pediatric Acute Respiratory Distress Syndrome?1 passage
• Does Armodafinil Improve Driving Task Performance and Weight Loss in Sleep Apnea? A Randomized Trial.1 passage
• Does Continuous Positive Airway Pressure Have the "Power" to Improve Glycemic Control in Patients with Type II Diabetes and Obstructive Sleep Apnea?1 passage
• Does Extracorporeal Membrane Oxygenation Improve Survival in Pediatric Acute Respiratory Failure?1 passage
• Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.1 passage
• Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.1 passage
• Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis.1 passage
• Dynamic Metabolic Risk Profiling of World Trade Center Lung Disease: A Longitudinal Cohort Study.1 passage
• Dynamic Upper Airway Imaging during Wakefulness in Obese Subjects with and without Sleep Apnea.1 passage
• Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies.1 passage
• Dynamics of the Upper Respiratory Tract Microbiota and its Association with Mortality in COVID-19.1 passage
• Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis.1 passage
• E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion.1 passage
• E-Cigarette or Vaping Product Use-associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report.1 passage
• Early Bacterial Identification Among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Cohort Study.1 passage
• Early Bactericidal Activity of Different Isoniazid Doses for Drug Resistant TB (INHindsight): A Randomized Open-label Clinical Trial.1 passage
• Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.1 passage
• Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.1 passage
• Early High-Frequency Oscillatory Ventilation in Pediatric Acute Respiratory Failure. A Propensity Score Analysis.1 passage
• Early High-Volume Hemofiltration versus Standard Care for Post-Cardiac Surgery Shock. The HEROICS Study.1 passage
• Early Immune Function and Duration of Organ Dysfunction in Critically III Children with Sepsis.1 passage
• Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in1 passage
• Early Intravascular Events Are Associated with Development of Acute Respiratory Distress Syndrome. A Substudy of the LIPS-A Clinical Trial.1 passage
• Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?1 passage
• Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome.1 passage
• Early Pulmonary Vascular Disease in Preterm Infants Is Associated with Late Respiratory Outcomes in Childhood.1 passage
• Early Pulmonary Vascular Disease in Young Adults Born Preterm.1 passage
• Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study.1 passage
• Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.1 passage
• Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.1 passage
• Early-Life Exposure to Traffic-related Air Pollution and Lung Function in Adolescence.1 passage
• Early-Life Exposure to the Great Smog of 1952 and the Development of Asthma.1 passage
• Echocardiographic Changes with Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome. Long-Term Pickwick Randomized Controlled Clinical Trial.1 passage
• Effect of Advanced HIV Infection on the Respiratory Microbiome.1 passage
• Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease.1 passage
• Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial.1 passage
• Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial.1 passage
• Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use.1 passage
• Effect of Early-Life Geohelminth Infections on the Development of Wheezing at 5 Years of Age.1 passage
• Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.1 passage
• Effect of Esophageal Pressure-guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial.1 passage
• Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.1 passage
• Effect of Including Important Clinical Variables on Accuracy of the Lung Allocation Score for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.1 passage
• Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial.1 passage
• Effect of Lowering Vt on Mortality in Acute Respiratory Distress Syndrome Varies with Respiratory System Elastance.1 passage
• Effect of Lung-Protective Ventilation in Organ Donors on Lung Procurement and Recipient Survival.1 passage
• Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.1 passage
• Effect of Obstructive Sleep Apnea Treatment on Renal Function in Patients with Cardiovascular Disease.1 passage
• Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.1 passage
• Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.1 passage
• Effect of Sleep-disordered Breathing Severity on Cognitive Performance Measures in a Large Community Cohort of Young School-aged Children.1 passage
• Effect of Supplemental Oxygen on Blood Pressure in Obstructive Sleep Apnea (SOX). A Randomized Continuous Positive Airway Pressure Withdrawal Trial.1 passage
• Effect of Telemedicine Education and Telemonitoring on Continuous Positive Airway Pressure Adherence. The Tele-OSA Randomized Trial.1 passage
• Effect of Weight Loss on Upper Airway Anatomy and the Apnea-Hypopnea Index. The Importance of Tongue Fat.1 passage
• Effect of ultrafiltration on sleep apnea and sleep structure in patients with end-stage renal disease.1 passage
• Effective Care Practices in Patients Receiving Prolonged Mechanical Ventilation. An Ethnographic Study.1 passage
• Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.1 passage
• Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function.1 passage
• Effects of Childhood Asthma on the Development of Obesity among School-aged Children.1 passage
• Effects of Inhaled Corticosteroid/Long-Acting β1 passage
• Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis.1 passage
• Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.1 passage
• Effects of Physician-targeted Pay for Performance on Use of Spontaneous Breathing Trials in Mechanically Ventilated Patients.1 passage
• Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation.1 passage
• Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study.1 passage
• Effects of a Household Air Pollution Intervention with Liquefied Petroleum Gas on Cardiopulmonary Outcomes in Peru. A Randomized Controlled Trial.1 passage
• Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter Randomized Controlled Trial (ACTIVATE-CF).1 passage
• Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.1 passage
• Effects of a Telephone- and Web-based Coping Skills Training Program Compared with an Education Program for Survivors of Critical Illness and Their Family Members. A Randomized Clinical Trial.1 passage
• Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial.1 passage
• Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.1 passage
• Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.1 passage
• Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study.1 passage
• Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial.1 passage
• Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.1 passage
• Effort to Breathe with Various Spontaneous Breathing Trial Techniques. A Physiologic Meta-analysis.1 passage
• Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial.1 passage
• Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.1 passage
• Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.1 passage
• Electronic Cigarette Use and Respiratory Symptoms in Adolescents.1 passage
• Electronic Cigarette Vapor with Nicotine Causes Airway Mucociliary Dysfunction Preferentially via TRPA1 Receptors.1 passage
• Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.1 passage
• End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease.1 passage
• Endobronchial Optical Coherence Tomography for the Diagnosis of Fibrotic Interstitial Lung Disease: A Light at the End of the Tunnel?1 passage
• Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.1 passage
• Endogenous Protease Inhibitors in Airway Epithelial Cells Contribute to Eosinophilic Chronic Rhinosinusitis.1 passage
• Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.1 passage
• Endothelial Responses in Sepsis.1 passage
• Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.1 passage
• Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.1 passage
• Endotoxin Exposure: Predictors and Prevalence of Associated Asthma Outcomes in the United States.1 passage
• Endotypic Mechanisms of Successful Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea.1 passage
• Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep Disordered Breathing.1 passage
• Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection.1 passage
• Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.1 passage
• Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement.1 passage
• Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.1 passage
• Ensuring Access to Albuterol in Schools: From Policy to Implementation. An Official ATS/AANMA/ALA/NASN Policy Statement.1 passage
• Epidemiology of Weaning Outcome according to a New Definition. The WIND Study.1 passage
• Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to1 passage
• Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways.1 passage
• Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models.1 passage
• Esophageal Manometry and Regional Transpulmonary Pressure in Lung Injury.1 passage
• Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.1 passage
• Etiology and Risk Factors for Mortality in an Adult Community-acquired Pneumonia Cohort in Malawi.1 passage
• Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.1 passage
• Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.1 passage
• Evaluating Risk Factors for Pediatric Post-extubation Upper Airway Obstruction Using a Physiology-based Tool.1 passage
• Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.1 passage
• Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.1 passage
• Evaluation of the Global Lung Initiative 2012 Reference Values for Spirometry in African Children.1 passage
• Evidence for Environmental-Human Microbiota Transfer at a Manufacturing Facility with Novel Work-related Respiratory Disease.1 passage
• Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency.1 passage
• Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.1 passage
• Evidence of Respiratory Syncytial Virus Spread by Aerosol. Time to Revisit Infection Control Strategies?1 passage
• Evidence-based Definition for Extensively Drug-Resistant Tuberculosis.1 passage
• Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort.1 passage
• Evolving Concepts of Asthma.1 passage
• Exacerbation Patterns in Adults with Asthma in England. A Population-based Study.1 passage
• Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.1 passage
• Excess Mucin Impairs Subglottic Epithelial Host Defense in Mechanically Ventilated Patients.1 passage
• Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.1 passage
• Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.1 passage
• Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.1 passage
• Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age.1 passage
• Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.1 passage
• Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease.1 passage
• Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease.1 passage
• Exome Sequencing of Neonatal Blood Spots and the Identification of Genes Implicated in Bronchopulmonary Dysplasia.1 passage
• Experiences and Expressions of Spirituality at the End of Life in the Intensive Care Unit.1 passage
• Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.1 passage
• Experimental Lung Injury Reduces Krüppel-like Factor 2 to Increase Endothelial Permeability via Regulation of RAPGEF3-Rac1 Signaling.1 passage
• Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.1 passage
• Exploring below the Tip of the Iceberg: The Prognostic Impact of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Primary Care.1 passage
• Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.1 passage
• Expression of the SARS-CoV-21 passage
• Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.1 passage
• Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.1 passage
• Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.1 passage
• Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis.1 passage
• Extracellular Vesicle Transfer from Mesenchymal Stromal Cells Modulates Macrophage Function in Acute Lung Injury. Basic Science and Clinical Implications.1 passage
• Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury Through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells.1 passage
• Extracorporeal Life Support in Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome. Decide Wisely, Early, and in a Personalized Way.1 passage
• Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study.1 passage
• Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort!1 passage
• Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?1 passage
• Extracorporeal Membrane Oxygenation instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19-associated Acute Respiratory Distress Syndrome.1 passage
• Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction.1 passage
• Ezrin, a Membrane Cytoskeleton Cross-Linker Protein, as a Marker of Epithelial Damage in Asthma.1 passage
• FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.1 passage
• FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.1 passage
• FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema.1 passage
• FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic Fibrosis.1 passage
• Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.1 passage
• Factors Associated with Functional Recovery among Older Intensive Care Unit Survivors.1 passage
• Factors Associated with Persistence of Severe Asthma from Late Adolescence to Early Adulthood.1 passage
• Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.1 passage
• Favorable Neurocognitive Outcome with Low Tidal Volume Ventilation after Cardiac Arrest.1 passage
• Feasibility of Measuring Face-to-Face Interactions among ICU Healthcare Professionals Using Wearable Sociometric Badges.1 passage
• Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.1 passage
• Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease.1 passage
• Female Smokers Are at Greater Risk of Airflow Obstruction Than Male Smokers. UK Biobank.1 passage
• Fetal Origins of Asthma: A Longitudinal Study from Birth to Age 36 Years.1 passage
• Fetal and Infant Growth Patterns and Risk of Lower Lung Function and Asthma. The Generation R Study.1 passage
• Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects.1 passage
• Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value.1 passage
• Fifty Years of Research in ARDS. Genomic Contributions and Opportunities.1 passage
• Fifty Years of Research in ARDS. Insight into Acute Respiratory Distress Syndrome. From Models to Patients.1 passage
• Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?1 passage
• Fifty Years of Research in ARDS. Long-Term Follow-up after Acute Respiratory Distress Syndrome. Insights for Managing Medical Complexity after Critical Illness.1 passage
• Fifty Years of Research in ARDS. Mechanical Ventilation during Extracorporeal Support for Acute Respiratory Distress Syndrome. For Now, a Necessary Evil.1 passage
• Fifty Years of Research in ARDS. Respiratory Mechanics in Acute Respiratory Distress Syndrome.1 passage
• Fifty Years of Research in ARDS. Setting Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome.1 passage
• Fifty Years of Research in ARDS. Spontaneous Breathing during Mechanical Ventilation. Risks, Mechanisms, and Management.1 passage
• Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review.1 passage
• Fifty Years of Research in ARDS. Vt Selection in Acute Respiratory Distress Syndrome.1 passage
• Fine Particulate Air Pollution and Daily Mortality. A Nationwide Analysis in 272 Chinese Cities.1 passage
• Fine Particulate Matter and Emergency Room Visits for Respiratory Illness. Effect Modification by Oxidative Potential.1 passage
• First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial.1 passage
• First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation.1 passage
• Five-Year Mortality and Hospital Costs Associated with Surviving Intensive Care.1 passage
• Flow Cytometric Analysis of Mononuclear Phagocytes in Nondiseased Human Lung and Lung-Draining Lymph Nodes.1 passage
• Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.1 passage
• Fluid Balance Is Associated with Clinical Outcomes and Extravascular Lung Water in Children with Acute Asthma Exacerbation.1 passage
• Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts. A Cost-Effectiveness Analysis.1 passage
• Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.1 passage
• Follicular Helper-like T Cells in the Lung Highlight a Novel Role of B Cells in Sarcoidosis.1 passage
• Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis.1 passage
• Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.1 passage
• Frailty and Subsequent Disability and Mortality among Patients with Critical Illness.1 passage
• Functional Genomics of the Pediatric Obese Asthma Phenotype Reveal Enrichment of Rho-GTPase Pathways.1 passage
• Future Research Directions in Asthma. An NHLBI Working Group Report.1 passage
• Future Research Directions in Pneumonia. NHLBI Working Group Report.1 passage
• Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.1 passage
• Gender Differences in Authorship of Critical Care Literature.1 passage
• Gender Parity in Critical Care Medicine.1 passage
• Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease.1 passage
• Gene Expression Profiling in Blood Provides Reproducible Molecular Insights into Asthma Control.1 passage
• Gene Promoter Hypermethylation Detected in Sputum Predicts FEV1 passage
• General and Organ Fat Assessed by Magnetic Resonance Imaging and Respiratory Outcomes in Childhood.1 passage
• Generation of Pulmonary Endothelial Progenitor Cells for Cell-based Therapy Using Interspecies Mouse-Rat Chimeras.1 passage
• Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.1 passage
• Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.1 passage
• Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.1 passage
• Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.1 passage
• Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma.1 passage
• Genome-Wide Association Study in Acute Respiratory Distress Syndrome. Finding the Needle in the Haystack to Advance Our Understanding of Acute Respiratory Distress Syndrome.1 passage
• Genome-Wide Association Study in African Americans with Acute Respiratory Distress Syndrome Identifies the Selectin P Ligand Gene as a Risk Factor.1 passage
• Genome-Wide Association Study of 58 Individuals with Fibrosing Mediastinitis Reveals Possible Underlying Genetic Susceptibility.1 passage
• Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.1 passage
• Genome-Wide Association Study of the Genetic Determinants of Emphysema Distribution.1 passage
• Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells.1 passage
• Genome-Wide Interaction Analysis of Air Pollution Exposure and Childhood Asthma with Functional Follow-up.1 passage
• Genome-Wide Methylation Study Identifies an IL-13-induced Epigenetic Signature in Asthmatic Airways.1 passage
• Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.1 passage
• Genomic Underpinnings of Tumor Behavior in1 passage
• Global Initiative for Asthma (GINA) Strategy 2021 - Executive Summary and Rationale for Key Changes.1 passage
• Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.1 passage
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.1 passage
• Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.1 passage
• Glutathione1 passage
• Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China.1 passage
• Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.1 passage
• Gradual Aeration at Birth Is More Lung Protective Than a Sustained Inflation in Preterm Lambs.1 passage
• Gray Matter Hypertrophy and Thickening with Obstructive Sleep Apnea in Middle-aged and Older Adults.1 passage
• Grief Symptoms in Relatives Who Experienced Organ Donation Requests in the ICU.1 passage
• Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.1 passage
• HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.1 passage
• HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.1 passage
• Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis.1 passage
• Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study.1 passage
• Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.1 passage
• Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.1 passage
• Herpesviruses: Silent Instigators of Lung Injury after Hematopoietic Cell Transplant.1 passage
• Heterogeneity in the Effects of Reward- and Deposit-based Financial Incentives on Smoking Cessation.1 passage
• High Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in COVID-19 Patients.1 passage
• High Pleural Pressure Prevents Alveolar Overdistension and Hemodynamic Collapse in ARDS with Class III Obesity.1 passage
• High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.1 passage
• High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences.1 passage
• High-Dose Vitamin D1 passage
• High-Flow Oxygen, Positive End-Expiratory Pressure, and the Berlin Definition of Acute Respiratory Distress Syndrome: Are They Mutually Exclusive?1 passage
• Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.1 passage
• Home Dust Allergen Exposure is Associated with Outcomes Among Sensitized Individuals with COPD.1 passage
• Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.1 passage
• Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.1 passage
• Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Home Oxygen in Chronic Obstructive Pulmonary Disease.1 passage
• Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition.1 passage
• Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective.1 passage
• Hospital-Level Variation in Death for Critically Ill Patients with COVID-19.1 passage
• Hospitalization Type and Subsequent Severe Sepsis.1 passage
• Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.1 passage
• Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.1 passage
• Hourly Kinetics of Critical Organ Dysfunction in Extremely Preterm Infants.1 passage
• House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway.1 passage
• How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?1 passage
• Human Lung Conventional Dendritic Cells Orchestrate Lymphoid Neogenesis during Chronic Obstructive Pulmonary Disease.1 passage
• Human Lung DNA Methylation Quantitative Trait Loci Colocalize with Chronic Obstructive Pulmonary Disease Genome-Wide Association Loci.1 passage
• Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD11 passage
• Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease.1 passage
• Human trachealis and main bronchi smooth muscle are normoresponsive in asthma.1 passage
• Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.1 passage
• Hyperoxia Injury in the Developing Lung Is Mediated by Mesenchymal Expression of Wnt5A.1 passage
• Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.1 passage
• Hypoxic Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in Asthma.1 passage
• Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease.1 passage
• IFN-stimulated Gene Expression, Type 2 Inflammation, and Endoplasmic Reticulum Stress in Asthma.1 passage
• IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells.1 passage
• IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.1 passage
• IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.1 passage
• IL-25 Receptor Expression on Airway Dendritic Cells after Allergen Challenge in Subjects with Asthma.1 passage
• IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses1 passage
• Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury.1 passage
• Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy.1 passage
• Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.1 passage
• Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.1 passage
• Identification of Four Novel Loci in Asthma in European American and African American Populations.1 passage
• Identification of Functional Variants in the FAM13A Chronic Obstructive Pulmonary Disease Genome-Wide Association Study Locus by Massively Parallel Reporter Assays.1 passage
• Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.1 passage
• Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care: NHLBI Working Group Report.1 passage
• Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories.1 passage
• Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.1 passage
• Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.1 passage
• Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.1 passage
• Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study.1 passage
• Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.1 passage
• Imaging the Respiratory Transition at Birth: Unraveling the Complexities of the First Breaths of Life.1 passage
• Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia.1 passage
• Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.1 passage
• Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.1 passage
• Impact of 24/7 In-Hospital Intensivist Coverage on Outcomes in Pediatric Intensive Care. A Multicenter Study.1 passage
• Impact of Age and Sex on Response to Asthma Therapy.1 passage
• Impact of Chronic Obstructive Pulmonary Disease on Immune-based Treatment for Lung Cancer. Moving toward Disease Interception.1 passage
• Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States.1 passage
• Impact of Mandibular Advancement Therapy on Endothelial Function in Severe Obstructive Sleep Apnea.1 passage
• Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial.1 passage
• Impact of Preeclampsia on the Relationship between Maternal Asthma and Offspring Asthma. An Observation from the VDAART Clinical Trial.1 passage
• Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.1 passage
• Impact of Sleep Deprivation on Respiratory Motor Output and Endurance. A Physiological Study.1 passage
• Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.1 passage
• Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.1 passage
• Impaired Lung Function, Lung Disease, and Risk of Incident Dementia.1 passage
• Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages.1 passage
• Impaired Right Ventricular Performance Is Associated with Adverse Outcome after Hypoxic Ischemic Encephalopathy.1 passage
• Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.1 passage
• Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.1 passage
• Impaired nuclear translocation of the glucocorticoid receptor in corticosteroid-insensitive airway smooth muscle in severe asthma.1 passage
• Impairment of Immunoproteasome Function by Cigarette Smoke and in Chronic Obstructive Pulmonary Disease.1 passage
• Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.1 passage
• Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study.1 passage
• Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP.1 passage
• Improving Appropriate Neurologic Prognostication after Cardiac Arrest. A Stepped Wedge Cluster Randomized Controlled Trial.1 passage
• Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.1 passage
• Improving selection criteria for lung cancer screening. The potential role of emphysema.1 passage
• Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement.1 passage
• In Patients with ARDS, Optimal PEEP Should Not Be Determined Using the Intersection of Relative Collapse and Relative Overdistention.1 passage
• In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.1 passage
• Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients.1 passage
• Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients.1 passage
• Incidence and Risk Factors for Intensive Care Unit-related Post-traumatic Stress Disorder in Veterans and Civilians.1 passage
• Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study.1 passage
• Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?1 passage
• Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis.1 passage
• Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.1 passage
• Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.1 passage
• Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.1 passage
• Increased Capsaicin Sensitivity in Patients with Severe Asthma Is Associated with Worse Clinical Outcome.1 passage
• Increased Chronic Obstructive Pulmonary Disease Exacerbations of Likely Viral Etiology Follow Elevated Ambient Nitrogen Oxides.1 passage
• Increased Dead Space Ventilation Mediates Reduced Exercise Capacity in Systolic Heart Failure.1 passage
• Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study.1 passage
• Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.1 passage
• Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.1 passage
• Increased Impact of Air Pollution on Lung Function in Preterm vs. Term Infants: The BILD Study.1 passage
• Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.1 passage
• Increased Platelet Aggregation in Children and Adolescents with Sleep-disordered Breathing.1 passage
• Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.1 passage
• Increased resource use in lung transplant admissions in the lung allocation score era.1 passage
• Increasing Pulmonary Rehabilitation Uptake after Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation. Let's Rise to the Challenge.1 passage
• Indications and Effects of Plasma Transfusions in Critically Ill Children.1 passage
• Individualization of Positive End-Expiratory Pressure Setting in Patients with Acute Respiratory Distress Syndrome under Extracorporeal Membrane Oxygenation. Inputs from Electrical Impedance Tomography.1 passage
• Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children.1 passage
• Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.1 passage
• Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.1 passage
• Infectiousness of HIV-Seropositive Patients with Tuberculosis in a High-Burden African Setting.1 passage
• Inflammation and Coagulation during Critical Illness and Long-Term Cognitive Impairment and Disability.1 passage
• Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.1 passage
• Inflammation without Vascular Leakage. Science Fiction No Longer?1 passage
• Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma.1 passage
• Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.1 passage
• Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.1 passage
• Influence of Lung Function and Sleep-disordered Breathing on All-Cause Mortality. A Community-based Study.1 passage
• Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.1 passage
• Informing Healthcare Decisions with Observational Research Assessing Causal Effect: An American Thoracic Society Statement Not Ready for Implementation.1 passage
• Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy.1 passage
• Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology.1 passage
• Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis.1 passage
• Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury.1 passage
• Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2.1 passage
• Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.1 passage
• Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms.1 passage
• Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Innate-like Gene Expression of Lung-Resident Memory CD81 passage
• Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.1 passage
• Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.1 passage
• Integrating Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome.1 passage
• Intensified Therapy with Inhaled Corticosteroids and Long-Acting β1 passage
• Intensifying Long-Acting β-Agonist/Corticosteroid Therapy at Acute Exacerbations of Chronic Obstructive Pulmonary Disease.1 passage
• Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.1 passage
• International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis.1 passage
• Interstitial Lung Disease in India. Results of a Prospective Registry.1 passage
• Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.1 passage
• Interventional Bronchoscopy.1 passage
• Interventions to Teach Inhaler Techniques, Risk Stratification of Asthma Exacerbations with Sputum Eosinophils, and High-Dose Infusion of Magnesium Sulfate for Severe Asthma.1 passage
• Intranasal Leptin Relieves Sleep-disordered Breathing in Mice with Diet-induced Obesity.1 passage
• Intrathoracic Airway Closure Impacts CO1 passage
• Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.1 passage
• Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations.1 passage
• Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.1 passage
• Is Computed Tomography Airway Count Related to Asthma Severity and Airway Structure and Function?1 passage
• Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.1 passage
• Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.1 passage
• Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR.1 passage
• Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.1 passage
• Joblessness and Lost Earnings after Acute Respiratory Distress Syndrome in a 1-Year National Multicenter Study.1 passage
• Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients.1 passage
• Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement.1 passage
• Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Laryngeal Dysfunction: Assessment and Management for the Clinician.1 passage
• Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.1 passage
• Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.1 passage
• Latent Tuberculosis Infection-associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?1 passage
• Lifetime Exposure to Ambient Pollution and Lung Function in Children.1 passage
• Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury.1 passage
• Lipoarabinomannan-Responsive Polycytotoxic T Cells Are Associated with Protection in Human Tuberculosis.1 passage
• Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.1 passage
• Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial.1 passage
• Localization of Macrophages in the Human Lung via Design-based Stereology.1 passage
• Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways.1 passage
• Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ.1 passage
• Long-Range Optical Coherence Tomography of the Neonatal Upper Airway for Early Diagnosis of Intubation-related Subglottic Injury.1 passage
• Long-Term Air Pollution Exposure and COVID-19 Mortality: A Patient-Level Analysis from New York City.1 passage
• Long-Term Azithromycin Reduces1 passage
• Long-Term Coarse Particulate Matter Exposure Is Associated with Asthma among Children in Medicaid.1 passage
• Long-Term Exposure to Ozone and Cause-Specific Mortality Risk in the United States.1 passage
• Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.1 passage
• Long-Term Mortality and Major Adverse Cardiovascular Events in Sepsis Survivors. A Nationwide Population-based Study.1 passage
• Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Long-Term Outcome after Prolonged Mechanical Ventilation. A Long-Term Acute-Care Hospital Study.1 passage
• Long-Term Outcomes after Protocolized Sedation versus Usual Care in Ventilated Pediatric Patients.1 passage
• Long-Term Outcomes after Severe Traumatic Brain Injury in Older Adults. A Registry-based Cohort Study.1 passage
• Long-Term Outcomes in ICU Patients with Delirium: A Population-based Cohort Study.1 passage
• Long-Term Ozone Exposure Increases the Risk of Developing the Acute Respiratory Distress Syndrome.1 passage
• Long-Term Ozone Exposure and Mortality in a Large Prospective Study.1 passage
• Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open Label Extension of a Phase 3 Randomized Controlled Trial.1 passage
• Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.1 passage
• Long-term Ozone Exposure and Small Airways Dysfunction: The China Pulmonary Health (CPH) Study.1 passage
• Long-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham heart study.1 passage
• Longevity and determinants of protective humoral immunity after pandemic influenza infection.1 passage
• Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis.1 passage
• Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.1 passage
• Longitudinal Modeling of Lung Function Trajectories in Smokers with and without Chronic Obstructive Pulmonary Disease.1 passage
• Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.1 passage
• Longitudinal Phenotypes of Respiratory Health in a High-Risk Urban Birth Cohort.1 passage
• Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.1 passage
• Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.1 passage
• Loss of Lung Health from Young Adulthood and Cardiac Phenotypes in Middle Age.1 passage
• Loss of Microbial Topography between Oral and Nasopharyngeal Microbiota and Development of Respiratory Infections Early in Life.1 passage
• Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.1 passage
• Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma.1 passage
• Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial.1 passage
• Lumacaftor/Ivacaftor in Patients Aged 6-11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR.1 passage
• Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.1 passage
• Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis.1 passage
• Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis.1 passage
• Lung Computational Models and the Role of the Small Airways in Asthma.1 passage
• Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.1 passage
• Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.1 passage
• Lung Development Genes and Adult Lung Function.1 passage
• Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation.1 passage
• Lung Function Abnormalities in Smokers with Ischemic Heart Disease.1 passage
• Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.1 passage
• Lung Function in African Infants in the Drakenstein Child Health Study. Impact of Lower Respiratory Tract Illness.1 passage
• Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.1 passage
• Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?1 passage
• Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.1 passage
• Lung Microbiota Is Related to Smoking Status and to Development of Acute Respiratory Distress Syndrome in Critically Ill Trauma Patients.1 passage
• Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients.1 passage
• Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis.1 passage
• Lung Pathology in U.S. Coal Workers with Rapidly Progressive Pneumoconiosis Implicates Silica and Silicates.1 passage
• Lung Recruiting Effect of Prone Positioning in Spontaneously Breathing Patients with COVID-19 Assessed by Electrical Impedance Tomography.1 passage
• Lung Recruitment Assessed by Respiratory Mechanics and Computed Tomography in Patients with Acute Respiratory Distress Syndrome. What Is the Relationship?1 passage
• Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.1 passage
• Lung Ultrasound for Critically Ill Patients.1 passage
• Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study.1 passage
• Lung Volume Reduction Surgery and Improvement of Endothelial Function and Blood Pressure in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.1 passage
• Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.1 passage
• Lung cancer screening.1 passage
• Lung- and Diaphragm-Protective Ventilation.1 passage
• Lung-Kidney Cross-Talk in the Critically Ill Patient.1 passage
• Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.1 passage
• Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects.1 passage
• Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data.1 passage
• Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data.1 passage
• Macrophage Elastase Induces TRAIL-mediated Tumor Cell Death through Its Carboxy-Terminal Domain.1 passage
• Macrophage Rac2 Is Required to Reduce the Severity of Cigarette Smoke-induced Pneumonia.1 passage
• Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.1 passage
• Macrophages, Inflammation, and Lung Cancer.1 passage
• Magentic Resonance Imaging Evaluation of Regional Lung Vts in Severe Neonatal Bronchopulmonary Dysplasia.1 passage
• Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis.1 passage
• Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.1 passage
• Making Medical Treatment Decisions for Unrepresented Patients in the ICU. An Official American Thoracic Society/American Geriatrics Society Policy Statement.1 passage
• Making Sense of the Noise: Toward Rational Treatment for Obstructive Sleep Apnea.1 passage
• Management of Advanced Pulmonary Sarcoidosis.1 passage
• Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.1 passage
• Mapping the 17q12-21.1 Locus for Variants Associated with Early-Onset Asthma in African Americans.1 passage
• Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis.1 passage
• Maternal Folate Intake during Pregnancy and Childhood Asthma in a Population-based Cohort.1 passage
• Matriptase, Protease-activated Receptor 2, and Idiopathic Pulmonary Fibrosis. Further Evidence for Signaling Pathway Redundancy in this Difficult-to-Treat Disease?1 passage
• Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity.1 passage
• Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences. A Prospective Cohort Study.1 passage
• Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). A Phase II, Multicenter Randomized Controlled Clinical Trial.1 passage
• Mechanical Stress and the Induction of Lung Fibrosis via the Midkine Signaling Pathway.1 passage
• Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort.1 passage
• Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and Practice.1 passage
• Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure.1 passage
• Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes.1 passage
• Mechanics of Breathing and Gas Exchange in Mechanically Ventilated Patients with COVID-19-associated Respiratory Failure.1 passage
• Mechanisms and Management of Asthma Exacerbations.1 passage
• Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.1 passage
• Mechanisms of Chronic Muscle Wasting and Dysfunction after an Intensive Care Unit Stay. A Pilot Study.1 passage
• Membrane and Capillary Components of Lung Diffusion in Infants with Bronchopulmonary Dysplasia.1 passage
• Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.1 passage
• Menopause Is Associated with Accelerated Lung Function Decline.1 passage
• Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.1 passage
• Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.1 passage
• Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer.1 passage
• Metabo-Endotypes of Asthma Reveal Differences in Lung Function: Discovery and Validation in two TOPMed Cohorts.1 passage
• Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.1 passage
• Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.1 passage
• Micro-Computed Tomography Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in Three-dimensional Granuloma Morphology.1 passage
• Micro-Computed Tomography Comparison of Preterminal Bronchioles in Centrilobular and Panlobular Emphysema.1 passage
• MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.1 passage
• MicroRNA let-7 Downregulates Ligand-Independent Estrogen Receptor-mediated Male-Predominant Pulmonary Fibrosis.1 passage
• MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.1 passage
• MicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia.1 passage
• MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-acquired Weakness.1 passage
• Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.1 passage
• Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples.1 passage
• Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.1 passage
• Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic.1 passage
• Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.1 passage
• Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program.1 passage
• Mobilizing Carbon Dioxide Stores. An Experimental Study.1 passage
• Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.1 passage
• More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea.1 passage
• Morphologic Characterization of Nerves in Whole-Mount Airway Biopsies.1 passage
• Morphometric Analysis of Explant Lungs in Cystic Fibrosis.1 passage
• Mortality Changes Associated with Mandated Public Reporting for Sepsis. The Results of the New York State Initiative.1 passage
• Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors.1 passage
• Mortality from Pulmonary Hypertension in the Pediatric Cardiac ICU.1 passage
• Moving toward true inclusion of racial/ethnic minorities in federally funded studies. A key step for achieving respiratory health equality in the United States.1 passage
• Mucin Production and Hydration Responses to Mucopurulent Materials in Normal versus Cystic Fibrosis Airway Epithelia.1 passage
• Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.1 passage
• Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to Aeroallergens.1 passage
• Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers.1 passage
• Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.1 passage
• Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and Intermediate Lactate Values.1 passage
• Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.1 passage
• Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia.1 passage
• Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.1 passage
• Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma.1 passage
• Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.1 passage
• Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.1 passage
• NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation.1 passage
• Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial Pathogens.1 passage
• Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.1 passage
• National Institute of Environmental Health Sciences: 50 Years of Advancing Science and Improving Lung Health.1 passage
• Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.1 passage
• Natural History of Cognitive Impairment in Critical Illness Survivors. A Systematic Review.1 passage
• Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study.1 passage
• Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease.1 passage
• Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine.1 passage
• Neighborhood-level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.1 passage
• Neighborhoods with Greater Prevalence of Minority Residents Have Lower Continuous Positive Airway Pressure Adherence.1 passage
• Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth.1 passage
• Neonatal Pulmonary Magnetic Resonance Imaging of Bronchopulmonary Dysplasia Predicts Short-Term Clinical Outcomes.1 passage
• Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.1 passage
• Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies.1 passage
• Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.1 passage
• Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.1 passage
• New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part.1 passage
• New Opioid Use after Invasive Mechanical Ventilation and Hospital Discharge.1 passage
• New Physical, Mental, and Cognitive Problems 1 Year after ICU Admission: A Prospective Multicenter Study.1 passage
• New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study.1 passage
• New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations.1 passage
• New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense.1 passage
• Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE).1 passage
• Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.1 passage
• Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery.1 passage
• Nocturnal Oximetry-based Evaluation of Habitually Snoring Children.1 passage
• Nocturnal hypoxemia severity and renin-angiotensin system activity in obstructive sleep apnea.1 passage
• Non-REM Apnea and Hypopnea Duration Varies across Population Groups and Physiologic Traits.1 passage
• Noncommunicable Lung Disease in Sub-Saharan Africa. A Community-based Cross-Sectional Study of Adults in Urban Malawi.1 passage
• Noncommunicable Respiratory Disease and Air Pollution Exposure in Malawi (CAPS). A Cross-Sectional Study.1 passage
• Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.1 passage
• Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease.1 passage
• Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.1 passage
• Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study.1 passage
• Noninvasive Ventilation with Helium/Oxygen in Chronic Obstructive Pulmonary Disease Exacerbations. When Physiologic Improvement Does Not Translate into Clinical Benefit.1 passage
• Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma.1 passage
• Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis.1 passage
• Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response.1 passage
• Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome.1 passage
• Novel Molecular and Phenotypic Insights into Congenital Lung Malformations.1 passage
• Novel approaches are needed to develop tomorrow's antibacterial therapies.1 passage
• Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses.1 passage
• Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Obesity and Airway Dysanapsis in Children with and without Asthma.1 passage
• Obesity-related IL-18 Impairs T-Regulatory Cell Function and Promotes Lung Ischemia-Reperfusion Injury.1 passage
• Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Obstructive Apneas in a Mouse Model of Congenital Central Hypoventilation Syndrome.1 passage
• Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.1 passage
• Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study.1 passage
• Obstructive Sleep Apnea during REM Sleep and Cardiovascular Disease.1 passage
• Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective.1 passage
• Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.1 passage
• Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.1 passage
• Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.1 passage
• Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU.1 passage
• Official American Thoracic Society Clinical Practice Guidelines: Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing.1 passage
• Official American Thoracic Society technical standards: flexible airway endoscopy in children.1 passage
• Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.1 passage
• Official Executive Summary of an American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults.1 passage
• Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.1 passage
• Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10-Pulmonary Function Association.1 passage
• Omega-3 and Omega-6 Intake Modifies Asthma Severity and Response to Indoor Air Pollution in Children.1 passage
• On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments.1 passage
• One Molecule, Two Opposite Biological Effects: The Many Faces of Matrix Metalloproteases in the Pathogenesis of Idiopathic Pulmonary Fibrosis.1 passage
• Ontogeny and Biology of Human Small Airway Epithelial Club Cells.1 passage
• Opioid Use Increases the Risk of Delirium in Critically Ill Adults Independently of Pain.1 passage
• Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.1 passage
• Optimal Asthma Control: Time for a New Target.1 passage
• Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.1 passage
• Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.1 passage
• Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.1 passage
• Oral Vitamin C (500 mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial.1 passage
• Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.1 passage
• Outcome of Patients with Interstitial Lung Disease Treated with Extracorporeal Membrane Oxygenation for Acute Respiratory Failure.1 passage
• Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled Trial.1 passage
• Outcomes after Rehospitalization at the Same Hospital or a Different Hospital Following Critical Illness.1 passage
• Outcomes of Childhood Asthma and Wheezy Bronchitis. A 50-Year Cohort Study.1 passage
• Overdiagnosis in Lung Cancer Screening, Cost-Effectiveness of Computed Tomography Screening for Lung Cancer, and Decision Analysis of Need for Biopsy-proven Diagnosis before Stereotactic Ablative Radiotherapy for Lung Cancer.1 passage
• Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.1 passage
• Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.1 passage
• Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.1 passage
• Oxygen Toxicity in Critically Ill Adults.1 passage
• Ozone Exposure Increases Circulating Stress Hormones and Lipid Metabolites in Humans.1 passage
• Ozone, Fine Particulate Matter, and Chronic Lower Respiratory Disease Mortality in the United States.1 passage
• PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock.1 passage
• PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.1 passage
• PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis.1 passage
• Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.1 passage
• Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.1 passage
• Partial Neuromuscular Blockade during Partial Ventilatory Support in Sedated Patients with High Tidal Volumes.1 passage
• Partially Assisted Ventilation-induced Lung Injury in Early Acute Respiratory Distress Syndrome. When Real Life Is Different from Classical Physiology.1 passage
• Particle Depletion Does Not Remediate Acute Effects of Traffic-related Air Pollution and Allergen. A Randomized, Double-Blind Crossover Study.1 passage
• Particulate Matter and Cardiovascular Risk in Adults with Chronic Obstructive Pulmonary Disease.1 passage
• Passive Nocturnal Physiologic Monitoring Enables Early Detection of Exacerbations in Children with Asthma. A Proof-of-Concept Study.1 passage
• Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.1 passage
• Pathological Comparisons of Paraseptal and Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease.1 passage
• Patient Registries in Idiopathic Pulmonary Fibrosis.1 passage
• Patient and Family Engagement in the ICU. Untapped Opportunities and Underrecognized Challenges.1 passage
• Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.1 passage
• Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Pedometer Step Count Targets during Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.1 passage
• Performance of a Novel Algorithm Using Automated Digital Microscopy for Diagnosing Tuberculosis.1 passage
• Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.1 passage
• Permissive Underfeeding or Standard Enteral Feeding in High- and Low-Nutritional-Risk Critically Ill Adults. Post Hoc Analysis of the PermiT Trial.1 passage
• Persistent Tachypnea of Infancy. Usual and Aberrant.1 passage
• Personalized Transcriptomics Reveals Heterogeneous Immunophenotypes in Children with Viral Bronchiolitis.1 passage
• Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.1 passage
• Perspectives on Burnout from Pulmonary, Critical Care, and Sleep Medicine Division Directors.1 passage
• Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review.1 passage
• Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.1 passage
• Phenotype of Spirometric Impairment in an Aging Population.1 passage
• Phenotype of normal spirometry in an aging population.1 passage
• Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood.1 passage
• Phenotyping Pharyngeal Pathophysiology using Polysomnography in Patients with Obstructive Sleep Apnea.1 passage
• Physical Activity and Insomnia, Short Sleep and Insulin Resistance, and Effect of Poor Sleep on Children's Academic Performance.1 passage
• Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.1 passage
• Physical Activity, Air Pollution, and the Risk of Asthma and Chronic Obstructive Pulmonary Disease.1 passage
• Physicians Rarely Elicit Critically Ill Patients' Previously Expressed Treatment Preferences in Intensive Care Units.1 passage
• Physiologic Analysis and Clinical Performance of the Ventilatory Ratio in Acute Respiratory Distress Syndrome.1 passage
• Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure.1 passage
• Physiologic Responsiveness Should Guide Entry into Randomized Controlled Trials.1 passage
• Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure.1 passage
• Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease.1 passage
• Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.1 passage
• Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.1 passage
• Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.1 passage
• Plasma Cortisol, Aldosterone, and Ascorbic Acid Concentrations in Patients with Septic Shock Do Not Predict Treatment Effect of Hydrocortisone on Mortality. A Nested Cohort Study.1 passage
• Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.1 passage
• Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure.1 passage
• Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.1 passage
• Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome.1 passage
• Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.1 passage
• Platelet Extracellular Vesicles Drive Inflammasome-IL-1β-Dependent Lung Injury in Sickle Cell Disease.1 passage
• Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis.1 passage
• Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.1 passage
• Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion.1 passage
• Pleural Diseases: Pleurodesis via Indwelling Pleural Catheter, Dasatinib-induced Pleural Effusion, and IL-27 in Tuberculosis Pleural Effusion.1 passage
• Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.1 passage
• Pleural Plaques and the Risk of Lung Cancer in Asbestos-exposed Subjects.1 passage
• Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis1 passage
• Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation.1 passage
• Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.1 passage
• Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases.1 passage
• Positive End-Expiratory Pressure Lower Than the ARDS Network Protocol Is Associated with Higher Pediatric Acute Respiratory Distress Syndrome Mortality.1 passage
• Positive End-Expiratory Pressure Ventilation Induces Longitudinal Atrophy in Diaphragm Fibers.1 passage
• Post-traumatic Stress Disorder, Bronchodilator Response, and Incident Asthma in World Trade Center Rescue and Recovery Workers.1 passage
• Postnatal Alveologenesis Depends on FOXF1 Signaling in c-KIT1 passage
• Potential Strategies to Prevent Ventilator-associated Events.1 passage
• Potential for Lung Recruitment Estimated by the Recruitment-to-Inflation Ratio in Acute Respiratory Distress Syndrome. A Clinical Trial.1 passage
• Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.1 passage
• Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.1 passage
• Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials.1 passage
• Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.1 passage
• Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma.1 passage
• Predictive Accuracy of the Quick Sepsis-related Organ Failure Assessment Score in Brazil. A Prospective Multicenter Study.1 passage
• Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.1 passage
• Preeclampsia Associates with Asthma, Allergy, and Eczema in Childhood.1 passage
• Pregnancy Zone Protein Is Associated with Airway Infection, Neutrophil Extracellular Trap Formation, and Disease Severity in Bronchiectasis.1 passage
• Prenatal Ambient Ultrafine Particle Exposure and Childhood Asthma in the Northeastern United States.1 passage
• Prenatal Household Air Pollution Is Associated with Impaired Infant Lung Function with Sex-Specific Effects. Evidence from GRAPHS, a Cluster Randomized Cookstove Intervention Trial.1 passage
• Prenatal Nitrate Exposure and Childhood Asthma. Influence of Maternal Prenatal Stress and Fetal Sex.1 passage
• Prenatal Particulate Air Pollution and Asthma Onset in Urban Children. Identifying Sensitive Windows and Sex Differences.1 passage
• Prenatal, Early-Life, and Childhood Exposure to Air Pollution and Lung Function: The ALSPAC Cohort.1 passage
• Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement.1 passage
• Pretreatment with Antioxidants Augments the Acute Arterial Vasoconstriction Caused by Diesel Exhaust Inhalation.1 passage
• Prevalence and Population Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study.1 passage
• Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.1 passage
• Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers.1 passage
• Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.1 passage
• Primary Care Physicians Can Comprehensively Manage Patients with Sleep Apnea. A Noninferiority Randomized Controlled Trial.1 passage
• Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype.1 passage
• Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.1 passage
• Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia.1 passage
• Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.1 passage
• Progranulin Plays a Central Role in Host Defense during Sepsis by Promoting Macrophage Recruitment.1 passage
• Progression from Asthma to Chronic Obstructive Pulmonary Disease. Is Air Pollution a Risk Factor?1 passage
• Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.1 passage
• Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.1 passage
• Prostacyclin in Mechanically Ventilated Patients with COVID-19 and Severe Endotheliopathy: A Multicenter, Randomized, Clinical Trial.1 passage
• Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.1 passage
• Protective Role of Myelocytic Nitric Oxide Synthases against Hypoxic Pulmonary Hypertension in Mice.1 passage
• Protein Phosphatase 2A Reduces Cigarette Smoke-induced Cathepsin S and Loss of Lung Function.1 passage
• Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.1 passage
• Proteomic profiling reveals autoimmune targets in sarcoidosis.1 passage
• Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial.1 passage
• Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort.1 passage
• Pulmonary Abnormalities in Young, Light-Use Waterpipe (Hookah) Smokers.1 passage
• Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.1 passage
• Pulmonary Aptamer Signatures in Children's Interstitial and Diffuse Lung Disease.1 passage
• Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.1 passage
• Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK ICUs.1 passage
• Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos.1 passage
• Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary.1 passage
• Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance.1 passage
• Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.1 passage
• Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin.1 passage
• Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations1 passage
• Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.1 passage
• Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.1 passage
• Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.1 passage
• Pulmonary Rehabilitation after a Chronic Obstructive Pulmonary Disease Exacerbation: Impact on Readmission Risk in a Real-World Setting.1 passage
• Pulmonary Rehabilitation and Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Pulmonary Transplantation of Human Induced Pluripotent Stem Cell-derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis.1 passage
• Quantitative Assessment of Viral Dispersion Associated with Respiratory Support Devices in a Simulated Critical Care Environment.1 passage
• Quantitative Dual-Energy Computed Tomography Supports a Vascular Etiology of Smoking-induced Inflammatory Lung Disease.1 passage
• Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.1 passage
• Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study.1 passage
• Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.1 passage
• Quantitative Lipidomics in Pulmonary Alveolar Proteinosis.1 passage
• Quantitative Magnetic Resonance Imaging of Bronchopulmonary Dysplasia in the Neonatal Intensive Care Unit Environment.1 passage
• Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit.1 passage
• RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.1 passage
• Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.1 passage
• Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease.1 passage
• Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.1 passage
• Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health: Results of the CLEAN AIR STUDY.1 passage
• Randomized Controlled Ethanol Cookstove Intervention and Blood Pressure in Pregnant Nigerian Women.1 passage
• Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.1 passage
• Randomized Trial of Apneic Oxygenation during Endotracheal Intubation of the Critically Ill.1 passage
• Randomized Trial of Communication Facilitators to Reduce Family Distress and Intensity of End-of-Life Care.1 passage
• Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.1 passage
• Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial.1 passage
• Randomized intubation with polyurethane or conical cuffs to prevent pneumonia in ventilated patients.1 passage
• Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation.1 passage
• Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering.1 passage
• Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.1 passage
• Rapid automated microscopy for microbiological surveillance of ventilator-associated pneumonia.1 passage
• Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.1 passage
• Rare variants in RTEL1 are associated with familial interstitial pneumonia.1 passage
• Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.1 passage
• Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.1 passage
• Reappraisal of Ventilator-Free Days in Critical Care Research.1 passage
• Recent Trends in the Identification of Incidental Pulmonary Nodules.1 passage
• Reclassifying Acute Respiratory Distress Syndrome.1 passage
• Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.1 passage
• Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.1 passage
• Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement.1 passage
• Recovery after Acute Kidney Injury.1 passage
• Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes.1 passage
• Red Blood Cells Homeostatically Bind Mitochondrial DNA through TLR9 to Maintain Quiescence and to Prevent Lung Injury.1 passage
• Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.1 passage
• Reduced Exercise Capacity in Adults Born Very Low Birth Weight: A Population-Based Cohort Study.1 passage
• Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease.1 passage
• Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure.1 passage
• Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Regulation of 26S Proteasome Activity in Pulmonary Fibrosis.1 passage
• Regulatory T Cells Subvert Mycobacterial Containment in Patients Failing Extensively Drug-Resistant Tuberculosis Treatment.1 passage
• Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.1 passage
• Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis.1 passage
• Relationships among Maternal Stress and Depression, Type 2 Responses, and Recurrent Wheezing at Age 3 Years in Low-Income Urban Families.1 passage
• Relative Hypotension and Adverse Kidney-related Outcomes among Critically Ill Patients with Shock. A Multicenter, Prospective Cohort Study.1 passage
• Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).1 passage
• Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma.1 passage
• Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.1 passage
• Reply to Albert: Informing Healthcare Decisions with Observational Research Assessing Causal Effects: An American Thoracic Society Statement Not Ready for Implementation.1 passage
• Reply to Alexis: Controlled Chamber Studies Showed Protective Effect of Nonsteroidal Antiinflammatory Drugs against Ozone Exposure: The Stage Was Set for Broader Epidemiologic Investigation.1 passage
• Reply to Dorrington et al. and to Swenson: "Hypercapnic Pulmonary Vasoconstriction Contributes to Regional Perfusion Distribution: Relevance to Asthma" and "Hypercapnic Pulmonary Vasoconstriction as a Mechanism for Regional Perfusion Redistribution in Asthma".1 passage
• Reply to Dreyfuss and Gaudry: Might High-Frequency Oscillatory Ventilation Improve the Prognosis of More Severe Acute Respiratory Distress Syndrome? Not So Sure.1 passage
• Reply to Giesinger and McNamara: The Impact of Therapeutic Hypothermia on Pulmonary Hemodynamics of Meconium Aspiration Syndrome.1 passage
• Reply to Janssen and Wouters: Loss of Alveolar Attachments as a Pathomechanistic Link between Small Airway Disease and Emphysema.1 passage
• Reply to Kovesi, to Chabra, and to Farber: "Palivizumab Prophylaxis and Recurrent Wheezing" and "Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants" and "Imbalance in Level of Tobacco Smoke Exposure Between Groups Likely Explains the "Effect" of Palivizumab on Subsequent Wheezing".1 passage
• Reply to Morán-Mendoza and Khalil: Are Ground-Glass Opacities on Chest High-Resolution Computed Tomography a Manifestation of Airway Disease?1 passage
• Reply to Patel et al.: Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic Shock.1 passage
• Reply to Rambaud et al.: Do We Really Doubt Extracorporeal Membrane Oxygenation Efficacy in Pediatric Acute Respiratory Distress Syndrome?1 passage
• Reply to Riché et al.: Sevoflurane in Acute Respiratory Distress Syndrome: Are Lung Protection and Anesthesia Depth Influenced by Pulmonary Morphology?1 passage
• Reply to Rodrigues et al.: Increasing Physical Activity in Daily Life in Chronic Obstructive Pulmonary Disease: To Solve the Puzzle, Every Piece Counts.1 passage
• Reply to Sasso et al.: Are All Steps Created Equal? Revisiting Pedometer Use during Pulmonary Rehabilitation for Individuals Living with Chronic Obstructive Pulmonary Disease.1 passage
• Reply to Shekar and Schmidt: Integrating Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome.1 passage
• Reply to Sohal: Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease.1 passage
• Reply to Soo Hoo and Esquinas: Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease: Don't Shortchange Noninvasive Ventilation.1 passage
• Reply to Wijmans et al.: Optical Coherence Tomography: A Valuable Novel Tool for Assessing the Alveolar Compartment in Interstitial Lung Disease?1 passage
• Reply to van den Berg and van der Hoeven: In Patients with ARDS, Optimal PEEP Should Not Be Determined Using the Intersection of Relative Collapse and Relative Overdistention.1 passage
• Reply: "An alternative perspective regarding the 'myth of the workforce crisis'" and "Intensivist workforce in the United States: the crisis is real, not imagined".1 passage
• Reply: "Could Noninvasive Ventilation Failure Rates Be Underestimated in the LUNG SAFE Study?" and "High-Flow Oxygen, Positive End-Expiratory Pressure, and the Berlin Definition of Acute Respiratory Distress Syndrome: Are They Mutually Exclusive?"1 passage
• Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".1 passage
• Reply: "Procedural Considerations on the Use of Polyurethane and/or Conical Cuffs"; "Estimating the Risk of Ventilator-associated Pneumonia as a Function of Time"; "Is Tracheobronchial Colonization a Good Marker for Microaspiration in Intubated Critically Ill Patients?"; and "Translating In Vitro Research: Improving Endotracheal Tube Bench Test Methodology".1 passage
• Reply: Analytical Performance Requirements for Biomarker-based Studies Evaluating Continuous Positive Airway Pressure Effects in Obstructive Sleep Apnea.1 passage
• Reply: Does Continuous Positive Airway Pressure Have the "Power" to Improve Glycemic Control in Patients with Type II Diabetes and Obstructive Sleep Apnea?1 passage
• Reply: Epithelial-Mesenchymal Transition: A Necessary New Therapeutic Target in Chronic Obstructive Pulmonary Disease?1 passage
• Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?1 passage
• Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement.1 passage
• Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society Research Statement.1 passage
• Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement.1 passage
• Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.1 passage
• Resonance as the Mechanism of Daytime Periodic Breathing in Patients with Heart Failure.1 passage
• Resources and Geographical Access to Care for Severe Pediatric Pneumonia in Four Resource-Limited Settings.1 passage
• Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies.1 passage
• Respiratory Drive in Critically Ill Patients. Pathophysiology and Clinical Implications.1 passage
• Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.1 passage
• Respiratory Responses to Ozone Exposure. MOSES (The Multicenter Ozone Study in Older Subjects).1 passage
• Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study.1 passage
• Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD81 passage
• Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells.1 passage
• Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients.1 passage
• Respiratory and Cardiovascular Outcomes in Survivors of Extremely Preterm Birth at 19 Years.1 passage
• Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.1 passage
• Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate-to-Severe Asthma.1 passage
• Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.1 passage
• Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.1 passage
• Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.1 passage
• Retraction: Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1; Heightened Endoplasmic Reticulum Stress in the Lungs of Patients with Chronic Obstructive Pulmonary Disease: The Role of Nrf2-Regulated Proteasomal Activity.1 passage
• Reverse Trigger Phenotypes in Acute Respiratory Distress Syndrome.1 passage
• Reversing Mechanoinductive DSP Expression by CRISPR/dCas9-mediated Epigenome Editing.1 passage
• Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis.1 passage
• Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma.1 passage
• Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection.1 passage
• Right Heart Thrombi in Pulmonary Embolism, Association of Pulmonary Embolism with Acute Exacerbations of Chronic Obstructive Pulmonary Disease, and Catheter-directed Therapies for Acute Pulmonary Embolism.1 passage
• Right Ventricle-to-Left Ventricle Diameter Ratio Measurement Seems to Have No Role in Low-Risk Patients with Pulmonary Embolism Treated at Home Triaged by Hestia Criteria.1 passage
• Rising Billing for Intermediate Intensive Care among Hospitalized Medicare Beneficiaries between 1996 and 2010.1 passage
• Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.1 passage
• Risk Factors Associated with Asthma Development and Control in Children. Mouse Infestation, Antipyretics, Respiratory Viruses, and Allergic Sensitization.1 passage
• Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study.1 passage
• Risk Factors for Functional Decline and Impaired Quality of Life after Pediatric Respiratory Failure.1 passage
• Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.1 passage
• Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease.1 passage
• Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease: Don't Shortchange Noninvasive Ventilation.1 passage
• Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.1 passage
• Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.1 passage
• Role of Biologics in Asthma.1 passage
• Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition.1 passage
• Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.1 passage
• Roles of Periostin in Respiratory Disorders.1 passage
• Rural Residence and Poverty Are Independent Risk Factors for Chronic Obstructive Pulmonary Disease in the United States.1 passage
• S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis.1 passage
• SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.1 passage
• SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer.1 passage
• SP110b Controls Host Immunity and Susceptibility to Tuberculosis.1 passage
• SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.1 passage
• SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.1 passage
• Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.1 passage
• Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.1 passage
• Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.1 passage
• Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung Injury.1 passage
• Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia.1 passage
• Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling.1 passage
• Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype.1 passage
• Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.1 passage
• Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.1 passage
• Sepsis and Cancer: An Interplay of Friends and Foes.1 passage
• Serial Measurement of Cell-cycle Arrest Biomarkers [TIMP-2]•[IGFBP7] and Risk for Progression to Death, Dialysis or Severe Acute Kidney Injury in Patients with Septic Shock.1 passage
• Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis).1 passage
• Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.1 passage
• Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.1 passage
• Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.1 passage
• Severe Obstructive Sleep Apnea Is Associated with Alterations in the Nasal Microbiome and an Increase in Inflammation.1 passage
• Severe Persistent Allergic Rhinitis. Inflammation but No Histologic Features of Structural Upper Airway Remodeling.1 passage
• Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome.1 passage
• Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.1 passage
• Sex Steroid Hormones and Asthma in a Nationwide Study of U.S. Adults.1 passage
• Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.1 passage
• Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia.1 passage
• Shear Wave Elastography, a New Tool for Diaphragmatic Qualitative Assessment: A Translational Study.1 passage
• Short Stature and Access to Lung Transplantation in the United States. A Cohort Study.1 passage
• Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection.1 passage
• Short-Term Exposure to Ambient Air Pollution and Asthma Mortality.1 passage
• Should We Monitor Pulsus Paradoxus via Pulse Oximetry in Patients with COVID-19 and Acute Respiratory Failure?1 passage
• Signs of Gas Trapping in Normal Lung Density Regions in Smokers.1 passage
• Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial.1 passage
• Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs.1 passage
• Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.1 passage
• Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.1 passage
• Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell.1 passage
• Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.1 passage
• Single-Session Bronchial Thermoplasty Guided by1 passage
• Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study.1 passage
• Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.1 passage
• Sleep Apnea Heterogeneity, Phenotypes, and Cardiovascular Risk. Implications for Trial Design and Precision Sleep Medicine.1 passage
• Sleep Apnea Specific Hypoxic Burden, Symptom Subtypes and Risk of Cardiovascular Events and All-Cause Mortality.1 passage
• Sleep and Pathological Wakefulness at the Time of Liberation from Mechanical Ventilation (SLEEWE). A Prospective Multicenter Physiological Study.1 passage
• Sleep in the intensive care unit.1 passage
• Sleep-disordered Breathing and Incident Heart Failure in Older Men.1 passage
• Sleep-disordered Breathing and Insomnia as Cardiometabolic Risk Factors among U.S. Hispanics/Latinx(s).1 passage
• Sleep-disordered Breathing in Neuromuscular Disease.1 passage
• Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis.1 passage
• Small Molecule T315 Promotes Casitas B-Lineage Lymphoma-Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation.1 passage
• Smoking-Dependent Distal-to-Proximal Repatterning of the Adult Human Small Airway Epithelium.1 passage
• Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms.1 passage
• Solid Fuel Use and Risks of Respiratory Diseases. A Cohort Study of 280,000 Chinese Never-Smokers.1 passage
• Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.1 passage
• Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome.1 passage
• Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis.1 passage
• Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.1 passage
• Spatiotemporal Variations in Ambient Ultrafine Particles and the Incidence of Childhood Asthma.1 passage
• Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis.1 passage
• Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos).1 passage
• Sputum Antineutrophil Cytoplasmic Antibodies in Eosinophilic Granulomatosis with Polyangiitis. Time to Start Sampling the Right Compartment?1 passage
• Sputum Antineutrophil Cytoplasmic Antibodies in Serum Antineutrophil Cytoplasmic Antibody-Negative Eosinophilic Granulomatosis with Polyangiitis.1 passage
• Sputum Eosinophilia and Magnetic Resonance Imaging Ventilation Heterogeneity in Severe Asthma.1 passage
• Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.1 passage
• Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.1 passage
• Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.1 passage
• Standardized Intensive Care. Protocol Misalignment and Impact Misattribution.1 passage
• Staphylococcus aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell-derived Cytokines.1 passage
• Static and Dynamic Contributors to Ventilator-induced Lung Injury in Clinical Practice. Pressure, Energy, and Power.1 passage
• Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection.1 passage
• Stress and Bronchodilator Response in Children with Asthma.1 passage
• Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis.1 passage
• Submassive Pulmonary Embolism.1 passage
• Surprising Results from an Angiotensin-Converting Enzyme Inhibitor Trial in Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis.1 passage
• Survival of patients with stage IV lung cancer with diabetes treated with metformin.1 passage
• Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data.1 passage
• Sustained Coinfections with1 passage
• Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes.1 passage
• Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study.1 passage
• Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.1 passage
• Synergistic Association of House Endotoxin Exposure and Ambient Air Pollution with Asthma Outcomes.1 passage
• Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance.1 passage
• Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management.1 passage
• Systemic Corticosteroid Therapy May Delay Viral Clearance in Patients with Middle East Respiratory Syndrome Coronavirus Infection.1 passage
• Systems Biology and Clinical Practice in Respiratory Medicine. The Twain Shall Meet.1 passage
• T-SPOT.TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.1 passage
• TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.1 passage
• TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.1 passage
• TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2.1 passage
• Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial.1 passage
• Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.1 passage
• Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.1 passage
• Targeting p161 passage
• Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma.1 passage
• Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial.1 passage
• Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.1 passage
• Temporal Trends in Critical Care Outcomes in U.S. Minority-Serving Hospitals.1 passage
• Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort.1 passage
• Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.1 passage
• The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.1 passage
• The Airway Microbiota Modulates Effect of Azithromycin Treatment for Episodes of Recurrent Asthma-like Symptoms in Preschool Children: A Randomized Clinical Trial.1 passage
• The Association between Discharge Delay from Intensive Care and Patient Outcomes.1 passage
• The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.1 passage
• The Association between Supraphysiologic Arterial Oxygen Levels and Mortality in Critically Ill Patients. A Multicenter Observational Cohort Study.1 passage
• The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality.1 passage
• The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.1 passage
• The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.1 passage
• The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance.1 passage
• The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.1 passage
• The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.1 passage
• The Different Clinical Faces of Obstructive Sleep Apnea (OSA), OSA in Older Adults as a Distinctly Different Physiological Phenotype, and the Impact of OSA on Cardiovascular Events after Coronary Artery Bypass Surgery.1 passage
• The Early Change in Pa1 passage
• The Early Development of Wheeze. Environmental Determinants and Genetic Susceptibility at 17q21.1 passage
• The Effect of Cigarette Smoking on Lung Function in Young Adults with Asthma.1 passage
• The Effect of Epinephrine Dosing Intervals on Outcomes from Pediatric In-Hospital Cardiac Arrest.1 passage
• The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.1 passage
• The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.1 passage
• The Effect of Sleep Apnea on Cardiovascular Events in Different Acute Coronary Syndrome Phenotypes.1 passage
• The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes.1 passage
• The Effects of Alternative Resuscitation Strategies on Acute Kidney Injury in Patients with Septic Shock.1 passage
• The Effects of Live Attenuated Influenza Vaccine on Nasopharyngeal Bacteria in Healthy 2 to 4 Year Olds. A Randomized Controlled Trial.1 passage
• The Effects of Rare1 passage
• The Effects of a Video Intervention on Posthospitalization Pulmonary Rehabilitation Uptake. A Randomized Controlled Trial.1 passage
• The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A Position Paper of the Extracorporeal Life Support Organization.1 passage
• The Genetics of Pneumothorax.1 passage
• The Host Response in Patients with Sepsis Developing Intensive Care Unit-acquired Secondary Infections.1 passage
• The Immune Landscape of Non-Small-Cell Lung Cancer. Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures.1 passage
• The Impact of Nursing Delirium Preventive Interventions in the ICU: A Multicenter Cluster-randomized Controlled Clinical Trial.1 passage
• The Injurious Effects of Elevated or Nonelevated Respiratory Rate during Mechanical Ventilation.1 passage
• The Long-Term Oxygen Trial, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome, and Collaborative Management of Sleep Disorders.1 passage
• The Lung Microbiome in Health, Hypersensitivity Pneumonitis, and Idiopathic Pulmonary Fibrosis: A Heavy Bacterial Burden to Bear.1 passage
• The Many Roles of Cholesterol in Sepsis: A Review.1 passage
• The ORMDL3 Asthma Gene Regulates ICAM1 and Has Multiple Effects on Cellular Inflammation.1 passage
• The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.1 passage
• The POOR Get POORer: A Hypothesis for the Pathogenesis of Ventilator-induced Lung Injury.1 passage
• The Postinjury Inflammatory State and the Bone Marrow Response to Anemia.1 passage
• The Potential Effects of Policy-driven Air Pollution Interventions on Childhood Lung Development.1 passage
• The Practice of Respect in the ICU.1 passage
• The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.1 passage
• The Prevalence of Latent Tuberculosis Infection in the United States.1 passage
• The Projected Economic and Health Burden of Uncontrolled Asthma in the United States.1 passage
• The Quality of End-of-Life Care among ICU versus Ward Decedents.1 passage
• The RECOVER Program: Disability Risk Groups and 1-Year Outcome after 7 or More Days of Mechanical Ventilation.1 passage
• The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.1 passage
• The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.1 passage
• The Role of Exercise in a Weight-Loss Program on Clinical Control in Obese Adults with Asthma. A Randomized Controlled Trial.1 passage
• The Role of Lung Function in Adverse Health Outcomes Related to Sleep-disordered Breathing. New Insights into the Overlap Syndrome.1 passage
• The Role of Nicotine in the Effects of Maternal Smoking during Pregnancy on Lung Development and Childhood Respiratory Disease. Implications for Dangers of E-Cigarettes.1 passage
• The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway.1 passage
• The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea. An Official American Thoracic Society Clinical Practice Guideline.1 passage
• The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.1 passage
• The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia.1 passage
• The Sleep Apnea-Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality.1 passage
• The Timing of Early Antibiotics and Hospital Mortality in Sepsis.1 passage
• The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis.1 passage
• The Voice of Surrogate Decision-Makers. Family Responses to Prognostic Information in Chronic Critical Illness.1 passage
• The association between acute respiratory distress syndrome, delirium, and in-hospital mortality in intensive care unit patients.1 passage
• The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.1 passage
• The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension.1 passage
• The impact of the organization of high-dependency care on acute hospital mortality and patient flow for critically ill patients.1 passage
• The myth of the workforce crisis. Why the United States does not need more intensivist physicians.1 passage
• The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.1 passage
• The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative.1 passage
• The timing of discharge from the intensive care unit and subsequent mortality. A prospective, multicenter study.1 passage
• The utility of preoperative six-minute-walk distance in lung transplantation.1 passage
• Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.1 passage
• Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in1 passage
• Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.1 passage
• Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.1 passage
• Thinking Forward: Future-oriented Thinking among Patients with Tobacco-associated Thoracic Diseases and Their Surrogates.1 passage
• Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.1 passage
• Time to Revisit the Hospital Readmissions Reduction Program for Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Timing and Duration of Traffic-related Air Pollution Exposure and the Risk for Childhood Wheeze and Asthma.1 passage
• Timing of Renal Replacement Therapy for Severe Acute Kidney Injury in Critically Ill Patients.1 passage
• Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial.1 passage
• Timing of low tidal volume ventilation and intensive care unit mortality in acute respiratory distress syndrome. A prospective cohort study.1 passage
• Tissue Doppler Imaging of the Diaphragm in Healthy Subjects and Critically Ill Patients.1 passage
• Tissue-Specific Immunopathology in Fatal COVID-19.1 passage
• Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension.1 passage
• Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile.1 passage
• Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.1 passage
• Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.1 passage
• Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design.1 passage
• Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.1 passage
• Tracheal Intubation in the Critically Ill. Where We Came from and Where We Should Go.1 passage
• Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.1 passage
• Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis.1 passage
• Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial.1 passage
• Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.1 passage
• Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.1 passage
• Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.1 passage
• Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.1 passage
• Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.1 passage
• Translational Aspects of the Human Respiratory Virome.1 passage
• Transmission of Oscillatory Volumes into the Preterm Lung during Noninvasive High-Frequency Ventilation.1 passage
• Transpulmonary Pressure: The Importance of Precise Definitions and Limiting Assumptions.1 passage
• Transvenous Diaphragm Neurostimulation Mitigates Ventilation-associated Brain Injury.1 passage
• Treatment Trials in Young Patients with COPD and Pre-COPD Patients: Time to Move Forward.1 passage
• Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.1 passage
• Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland.1 passage
• Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012.1 passage
• Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.1 passage
• Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.1 passage
• Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.1 passage
• Two New Neutrophil Subsets Define a Discriminating Sepsis Signature.1 passage
• Ultrafine and Fine Particles and Hospital Admissions in Central Europe. Results from the UFIREG Study.1 passage
• Ultrathin Bronchoscopy with Multimodal Devices for Peripheral Pulmonary Lesions. A Randomized Trial.1 passage
• Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.1 passage
• Underdetection and Undertreatment of Dyspnea in Critically Ill Patients.1 passage
• Underdiagnosis and Overdiagnosis of Asthma.1 passage
• Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease.1 passage
• Underestimation of Patient Breathlessness by Nurses and Physicians during a Spontaneous Breathing Trial.1 passage
• Understanding Heterogeneity in Biologic Phenotypes of Acute Respiratory Distress Syndrome by Leukocyte Expression Profiles.1 passage
• Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management.1 passage
• Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice.1 passage
• Understanding the Current Role and Future Application of Extracorporeal Life Support in Acute Respiratory Distress Syndrome.1 passage
• Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.1 passage
• Understanding the anatomic basis for obstructive sleep apnea syndrome in adolescents.1 passage
• Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.1 passage
• Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.1 passage
• Unproven and Expensive before Proven and Cheap: Extracorporeal Membrane Oxygenation versus Prone Position in Acute Respiratory Distress Syndrome.1 passage
• Unstable Inflation Causing Injury. Insight from Prone Position and Paired Computed Tomography Scans.1 passage
• Update in Critical Care 2015.1 passage
• Update in Lung Cancer 2014.1 passage
• Update in Mechanical Ventilation, Sedation, and Outcomes 2014.1 passage
• Update in diffuse parenchymal lung disease, 2013.1 passage
• Update in sepsis and acute kidney injury 2014.1 passage
• Upper-Airway Collapsibility and Loop Gain Predict the Response to Oral Appliance Therapy in Patients with Obstructive Sleep Apnea.1 passage
• Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome.1 passage
• Urinary Leukotriene E1 passage
• Urinary Polycyclic Aromatic Hydrocarbon Metabolites and Altered Lung Function in Wuhan, China.1 passage
• Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline.1 passage
• Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock.1 passage
• Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial.1 passage
• Using Technology to Create a More Humanistic Approach to Integrating Palliative Care into the Intensive Care Unit.1 passage
• Utility of Endosonographic Mediastinal Lymph Node Staging in Lung Cancer, Withdrawal of Inhaled Steroids in Chronic Obstructive Pulmonary Disease, and Use of Mepolizumab in Severe Eosinophilic Asthma.1 passage
• Utility of Inferior Vena Cava Filters in Severe Pulmonary Embolism, Catheter-directed Therapy in Massive and Submassive Pulmonary Embolism, and HAS-BLED Score to Determine Risk of Major Hemorrhage in Pulmonary Embolism.1 passage
• Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.1 passage
• Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure.1 passage
• Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.1 passage
• Vascular Endothelial Mitochondrial Function Predicts Death or Pulmonary Outcomes in Preterm Infants.1 passage
• Ventilatory Drive Withdrawal Rather Than Reduced Genioglossus Compensation as a Mechanism of Obstructive Sleep Apnea in REM.1 passage
• Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome.1 passage
• Ventricular Dysfunction Is a Critical Determinant of Mortality in Congenital Diaphragmatic Hernia.1 passage
• Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.1 passage
• Vitamin C Prevents Offspring DNA Methylation Changes Associated with Maternal Smoking in Pregnancy.1 passage
• Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.1 passage
• Vitamin D Supplementation and the Risk of Colds in Patients with Asthma.1 passage
• Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation?1 passage
• Volume-controlled Ventilation Does Not Prevent Injurious Inflation during Spontaneous Effort.1 passage
• Waiting for Godot: Clinical Trials of Extracorporeal Membrane Oxygenation for Pediatric Respiratory Failure.1 passage
• Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.1 passage
• What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?1 passage
• What's New in Noninvasive Ventilation: Factors Associated with Failure, Patterns of Use in Acute Asthma, and the Role of New Interfaces.1 passage
• Who cares about preventing acute respiratory distress syndrome?1 passage
• Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.1 passage
• Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease.1 passage
• Whole-Genome Sequencing Identifies Novel Functional Loci Associated with Lung Function in Puerto Rican Youth.1 passage
• Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma.1 passage
• Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.1 passage
• Within-City Variation in Reactive Oxygen Species from Fine Particle Air Pollution and COVID-19.1 passage
• Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation.1 passage
• Women and Lung Disease. Sex Differences and Global Health Disparities.1 passage
• Wood Smoke Exposure Alters Human Inflammatory Responses to Viral Infection in a Sex-Specific Manner. A Randomized, Placebo-controlled Study.1 passage
• X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.1 passage
• XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia.1 passage
• XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.1 passage
• Xpert MTB/RIF Assay as a Substitute for Smear Microscopy in an Intermediate-Burden Setting.1 passage
• YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.1 passage
• YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1.1 passage
• Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.1 passage
• rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.1 passage
• rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia.1 passage